Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pertussis Vaccine”

344 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 344 results

Large-scale testing (Phase 3)Study completedNCT01086423
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine

Who this might be right for
TetanusPoliomyelitisAcellular Pertussis+2 more
GlaxoSmithKline 985
Post-approval studies (Phase 4)Study completedNCT01031303
What this trial is testing

Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi 123
Large-scale testing (Phase 3)Study completedNCT00148941
What this trial is testing

Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines

Who this might be right for
TetanusAcellular PertussisDiphtheria
GlaxoSmithKline 4,209
Large-scale testing (Phase 3)Study completedNCT01444781
What this trial is testing

Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants

Who this might be right for
DiphtheriaTetanusWhooping Cough+2 more
Sanofi Pasteur, a Sanofi Company 1,106
Large-scale testing (Phase 3)Study completedNCT01346293
What this trial is testing

Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age

Who this might be right for
TetanusDiphtheriaPertussis+2 more
Sanofi Pasteur, a Sanofi Company 3,372
Not applicableStudy completedNCT02112890
What this trial is testing

Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico

Who this might be right for
Hepatitis AViral Hepatitis Vaccines
GlaxoSmithKline 1,603
Large-scale testing (Phase 3)Study completedNCT06817187
What this trial is testing

Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine

Who this might be right for
Streptococcus Pneumoniae Infections
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 1,110
Testing effectiveness (Phase 2)Study completedNCT03541499
What this trial is testing

Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults

Who this might be right for
PertussisPertussis Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableStudy completedNCT03147898
What this trial is testing

Observational Study Describing the Immune Profile Induced By Pertussis Vaccines

Who this might be right for
Whooping CoughPertussis
Sanofi 90
Post-approval studies (Phase 4)Study completedNCT00255021
What this trial is testing

Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand

Who this might be right for
DiphtheriaTetanusPoliomyelitis+2 more
Sanofi 186
Testing effectiveness (Phase 2)Study completedNCT03566940
What this trial is testing

Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization Schedule

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 302
Not applicableStudy completedNCT04494581
What this trial is testing

GriCoVax Study in 4 Maternity Wards in the Ile-de-France Region

Who this might be right for
Pertussis VaccineHealthcare Worker Patient TransmissionPregnant Women+1 more
Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux 480
Post-approval studies (Phase 4)Study completedNCT00548171
What this trial is testing

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058

Who this might be right for
Acellular PertussisTetanusDiphtheria+1 more
GlaxoSmithKline 203
Testing effectiveness (Phase 2)UnknownNCT01584115
What this trial is testing

Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)

Who this might be right for
Cancer.Melanoma.Ovarian Cancer.+1 more
Instituto de Investigação em Imunologia 15
Not applicableStudy completedNCT01929291
What this trial is testing

Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in Korea

Who this might be right for
Diphtheria-Tetanus-acellular Pertussis Vaccines
GlaxoSmithKline 682
Large-scale testing (Phase 3)Study completedNCT00385255
What this trial is testing

Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults

Who this might be right for
Acellular PertussisDiphtheriaTetanus
GlaxoSmithKline 1,726
Not applicableStudy completedNCT03197597
What this trial is testing

EUpertstrain 4 Study of Bordetella Pertussis Isolates

Who this might be right for
Bordetella Pertussis, Whooping Cough
University of Turku 265
Large-scale testing (Phase 3)Study completedNCT02052596
What this trial is testing

Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and Older

Who this might be right for
Herpes Zoster
GlaxoSmithKline 935
Post-approval studies (Phase 4)Study completedNCT02145624
What this trial is testing

A Trial Comparing Two Pertussis-containing Vaccines in Pregnancy and Vaccine Responses in UK Mothers and Their Infants

Who this might be right for
Responses to Infant Immunisations
Public Health England 366
Testing effectiveness (Phase 2)Study completedNCT01171989
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

Who this might be right for
TetanusDiphtheriaHaemophilus Influenzae Type b+4 more
GlaxoSmithKline 391
Load More Results